Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
tsx:zyme | https://www.glassdoor.com?employer_id=963602 | 963602 | Apr 28th, 2024 12:00AM | Open | Zymeworks | Open | Company - Public | Biotech & Pharmaceuticals | Vancouver, Canada | 2003 | 3.60 | 67% | 54% | 62% | 4.00 | 3.40 | 3.30 | 3.40 | 3.90 | 3.10 | 11.00 | 3.00 | 4.00 | 9.00 | 15.00 | 42.00 | 55.00 | 30.00 | 26.19% | 7.143% | 9.524% | 21.429% | 35.714% | 0.00 | 95.00 | 0.37 | 0.26 | 0.37 | 0.83 | 0.04 | 0.04 | Kenneth Galbraith | Apr 28th, 2024 05:50PM | Apr 28th, 2024 05:50PM | Zymeworks | ||||||||||||
tsx:zyme | https://www.glassdoor.com?employer_id=963602 | 963602 | Apr 26th, 2024 12:00AM | Open | Zymeworks | Open | Company - Public | Biotech & Pharmaceuticals | Vancouver, Canada | 2003 | 3.60 | 67% | 54% | 62% | 4.00 | 3.40 | 3.30 | 3.40 | 3.90 | 3.10 | 12.00 | 3.00 | 5.00 | 9.00 | 15.00 | 44.00 | 55.00 | 30.00 | 27.273% | 6.818% | 11.364% | 20.455% | 34.091% | 0.00 | 95.00 | 0.37 | 0.26 | 0.37 | 0.83 | 0.04 | 0.04 | Kenneth Galbraith | Apr 25th, 2024 08:02PM | Apr 26th, 2024 09:38AM | Zymeworks | ||||||||||||
tsx:zyme | https://www.glassdoor.com?employer_id=963602 | 963602 | Apr 24th, 2024 12:00AM | Open | Zymeworks | Open | Company - Public | Biotech & Pharmaceuticals | Vancouver, Canada | 2003 | 3.60 | 67% | 54% | 62% | 4.00 | 3.40 | 3.30 | 3.40 | 3.90 | 3.10 | 12.00 | 3.00 | 5.00 | 9.00 | 15.00 | 44.00 | 55.00 | 30.00 | 27.273% | 6.818% | 11.364% | 20.455% | 34.091% | 0.00 | 95.00 | 0.37 | 0.26 | 0.37 | 0.83 | 0.04 | 0.04 | Kenneth Galbraith | Apr 24th, 2024 12:35PM | Apr 24th, 2024 12:35PM | Zymeworks | ||||||||||||
tsx:zyme | https://www.glassdoor.com?employer_id=963602 | 963602 | Apr 23rd, 2024 12:00AM | Open | Zymeworks | Open | Company - Public | Biotech & Pharmaceuticals | Vancouver, Canada | 2003 | 3.60 | 67% | 54% | 62% | 4.00 | 3.40 | 3.30 | 3.40 | 3.90 | 3.10 | 12.00 | 3.00 | 5.00 | 9.00 | 15.00 | 44.00 | 55.00 | 30.00 | 27.273% | 6.818% | 11.364% | 20.455% | 34.091% | 0.00 | 19.00 | 95.00 | 0.37 | 0.26 | 0.37 | 0.83 | 0.04 | 0.04 | Kenneth Galbraith | Apr 23rd, 2024 05:56PM | Apr 23rd, 2024 05:56PM | Zymeworks | |||||||||||
tsx:zyme | https://www.glassdoor.com?employer_id=963602 | 963602 | Apr 21st, 2024 12:00AM | Open | Zymeworks | Open | Company - Public | Biotech & Pharmaceuticals | Vancouver, Canada | 2003 | 3.60 | 67% | 54% | 62% | 4.00 | 3.40 | 3.30 | 3.40 | 3.90 | 3.10 | 12.00 | 3.00 | 5.00 | 9.00 | 15.00 | 44.00 | 55.00 | 30.00 | 27.273% | 6.818% | 11.364% | 20.455% | 34.091% | 0.00 | 95.00 | 0.37 | 0.26 | 0.37 | 0.83 | 0.04 | 0.04 | Kenneth Galbraith | Apr 21st, 2024 05:53PM | Apr 21st, 2024 05:53PM | Zymeworks | ||||||||||||
tsx:zyme | https://www.glassdoor.com?employer_id=963602 | 963602 | Apr 20th, 2024 12:00AM | Open | Zymeworks | Open | Company - Public | Biotech & Pharmaceuticals | Vancouver, Canada | 2003 | 3.60 | 67% | 54% | 62% | 4.00 | 3.40 | 3.30 | 3.40 | 3.90 | 3.10 | 12.00 | 3.00 | 5.00 | 9.00 | 15.00 | 44.00 | 55.00 | 30.00 | 27.273% | 6.818% | 11.364% | 20.455% | 34.091% | 0.00 | 95.00 | 0.37 | 0.26 | 0.37 | 0.83 | 0.04 | 0.04 | Kenneth Galbraith | Apr 20th, 2024 06:09PM | Apr 20th, 2024 06:09PM | Zymeworks | ||||||||||||
tsx:zyme | https://www.glassdoor.com?employer_id=963602 | 963602 | Apr 19th, 2024 12:00AM | Open | Zymeworks | Open | Company - Public | Biotech & Pharmaceuticals | Vancouver, Canada | 2003 | 3.60 | 67% | 54% | 62% | 4.00 | 3.40 | 3.30 | 3.40 | 3.90 | 3.10 | 12.00 | 3.00 | 5.00 | 9.00 | 15.00 | 44.00 | 55.00 | 30.00 | 27.273% | 6.818% | 11.364% | 20.455% | 34.091% | 0.00 | 95.00 | 0.37 | 0.26 | 0.37 | 0.83 | 0.04 | 0.04 | Kenneth Galbraith | Apr 19th, 2024 09:13AM | Apr 19th, 2024 09:13AM | Zymeworks | ||||||||||||
tsx:zyme | https://www.glassdoor.com?employer_id=963602 | 963602 | Apr 18th, 2024 12:00AM | Open | Zymeworks | Open | Company - Public | Biotech & Pharmaceuticals | Vancouver, Canada | 2003 | 3.60 | 67% | 54% | 62% | 4.00 | 3.40 | 3.30 | 3.40 | 3.90 | 3.10 | 12.00 | 3.00 | 5.00 | 9.00 | 15.00 | 44.00 | 55.00 | 30.00 | 27.273% | 6.818% | 11.364% | 20.455% | 34.091% | 0.00 | 95.00 | 0.37 | 0.26 | 0.37 | 0.83 | 0.04 | 0.04 | Kenneth Galbraith | Apr 18th, 2024 07:31PM | Apr 18th, 2024 07:31PM | Zymeworks | ||||||||||||
tsx:zyme | https://www.glassdoor.com?employer_id=963602 | 963602 | Apr 17th, 2024 12:00AM | Open | Zymeworks | Open | Company - Public | Biotech & Pharmaceuticals | Vancouver, Canada | 2003 | 3.60 | 67% | 54% | 62% | 4.00 | 3.40 | 3.30 | 3.40 | 3.90 | 3.10 | 12.00 | 3.00 | 6.00 | 9.00 | 15.00 | 45.00 | 55.00 | 30.00 | 26.667% | 6.667% | 13.333% | 20% | 33.333% | 0.00 | 20.00 | 95.00 | 0.37 | 0.26 | 0.37 | 0.83 | 0.04 | 0.04 | Kenneth Galbraith | Apr 17th, 2024 04:02PM | Apr 17th, 2024 04:02PM | Zymeworks | |||||||||||
tsx:zyme | https://www.glassdoor.com?employer_id=963602 | 963602 | Apr 16th, 2024 12:00AM | Open | Zymeworks | Open | Company - Public | Biotech & Pharmaceuticals | Vancouver, Canada | 2003 | 3.60 | 67% | 54% | 62% | 4.00 | 3.40 | 3.30 | 3.40 | 3.90 | 3.10 | 12.00 | 4.00 | 6.00 | 9.00 | 15.00 | 46.00 | 55.00 | 30.00 | 26.087% | 8.696% | 13.043% | 19.565% | 32.609% | 0.00 | 95.00 | 0.37 | 0.26 | 0.37 | 0.83 | 0.04 | 0.04 | Kenneth Galbraith | Apr 16th, 2024 12:13PM | Apr 16th, 2024 12:13PM | Zymeworks |